Not applicableEnrolling By InvitationNCT07023965
What this trial is testing
Follow-up Study Using Gene Therapy for Critical Limb Ischemia (NL003-CLI-III-L)
Who this might be right for
Peripheral Arterial Disease(PAD)Arterial Occlusive DiseaseArteriosclerosis Obliterans+4 more
Beijing Northland Biotech. Co., Ltd. 542